Basics Regencell Bioscience Holdings Limited IPO Date: July 16, 2021 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $8.03B Activated in VL: True Average Daily Range Avg Daily Range: $3.10 | 6.50% Avg Daily Range (30 D): $0.59 | 4.28% Avg Daily Range (90 D): $0.57 | 3.94% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 52 Avg Inst. Trade: $.96M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $.85M Avg Inst. Trade Volume: .34M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $.86M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $.69M Avg Closing Volume: 170.87K     News Nov 24, 2025 @ 2:05 PM This Stock Soared 9,800% in 2025. Here's 1 Key Rea... Source: Selena Maranjian Nov 22, 2025 @ 4:04 PM Bragar Eagel & Squire, P.C. Continues Investigatio... Source: Bragar Eagel & Squire, P.C. Jul 24, 2024 @ 9:27 AM Why Enphase Energy Shares Are Trading Higher; Here... Source: Avi Kapoor Jun 28, 2023 @ 5:04 PM Why Eton Pharmaceuticals Shares Are Trading Lower ... Source: Lisa Levin Jun 5, 2023 @ 5:09 PM Why Amedisys Shares Are Trading Higher By 14%? Her... Source: Lisa Levin Financials   TTM Q4 2017 FY 2017 Basic EPS $.72 $.19 $.72 Diluted EPS $.72 $.19 $.72 Revenue $ 3.16B $ 861.6M $ 3.16B Gross Profit $ $ $ Net Income / Loss $ 112.3M $ 28.9M $ 112.3M Operating Income / Loss $ 271.7M $ 90.7M $ 271.7M Cost of Revenue $ $ $ Net Cash Flow $ -17.7M $ 39.3M $ -17.7M PE Ratio 22.29     Splits Jun 16, 2025:   38:1